Alcon and RxSight have announced a $200 million collaboration to develop post-operative adjustable presbyopic correction intraocular lenses (PCIOLs), marking a strategic pivot for Alcon after years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results